International Journal of Rheumatology

The Assessment of Disease Activity in Rheumatic Diseases

Publishing date
25 Oct 2013
Submission deadline
07 Jun 2013

1Weill Cornell Medical College in Qatar, Education City, Doha, Qatar

2Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, University of Toronto, 399 Bathurst Street, Room 1-415 E W, Toronto, ON, Canada M5T 2S8

3St. Vincent's Hospital, The University of Melbourne, 41 Victoria Parade, Fitzroy, VIC 3065, Australia

4Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, P.O. Box 11-0236, Riad El-Solh, Beirut 1107 2020, Lebanon

The Assessment of Disease Activity in Rheumatic Diseases


Monitoring of disease activity in rheumatology is challenging and depends on the use of valid and reliable instruments that enable healthcare providers and patients to quantify and evaluate disease activity in a standardized way. In addition, such measures may be used to determine the efficacy of interventions, guide patient care, develop evidence-based recommendations, and direct health policy.

To date, the usefulness of disease activity measures in clinical practice and research has been variable. Measures used in clinical trials may be too cumbersome to use in clinical practice and practitioners may be using methods that have not been validated or culturally adapted.

We invite authors to submit original research and review articles that describe and evaluate existing tools for measurement of disease activity, and provide innovative ideas for future developments in this area. We also welcome reports of studies assessing the usefulness and applicability of disease activity measures in clinical practice. Potential topics include, but are not limited to:

  • Characteristics of disease activity measures: validity, reliability, and responsiveness
  • Challenges in the transfer of disease activity measures from the clinical-trials setting to physicians' offices
  • Issues in the use of disease activity measures across cultures
  • Importance of clinical skills in accurate and reliable assessment of disease activity
  • Assessing improvement, minimal disease activity, and remission in rheumatoid arthritis
  • Composite measures of disease activity in psoriatic arthritis
  • Assessing disease activity in systemic lupus erythematosus
  • Instruments for measuring disease activity in ankylosing spondylitis
  • Measurement of disease activity in systemic sclerosis, Sjogren's syndrome, systemic vasculitis, polymyositis and dermatomyositis, and juvenile chronic arthritis
  • Disease activity instruments and physician reimbursement

Before submission authors should carefully read over the journal's Author Guidelines, which are located at Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at according to the following timetable:

International Journal of Rheumatology
 Journal metrics
See full report
Acceptance rate11%
Submission to final decision79 days
Acceptance to publication19 days
Journal Citation Indicator0.460
Impact Factor2.3
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.